Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke
Aims - To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway. Methods and results - In the population-based Tromsø Study 2015–16 (attendance...
Published in: | European Journal of Preventive Cardiology |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Cambrigde University Press
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10037/23027 https://doi.org/10.1093/eurjpc/zwab050 |
id |
ftunivtroemsoe:oai:munin.uit.no:10037/23027 |
---|---|
record_format |
openpolar |
spelling |
ftunivtroemsoe:oai:munin.uit.no:10037/23027 2023-05-15T18:34:31+02:00 Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke Hopstock, Laila Arnesdatter Morseth, Bente Cook, Sarah Eggen, Anne Elise Grimsgaard, Sameline Lundblad, Marie Wasmuth Løchen, Maja-Lisa Mathiesen, Ellisiv B. Nilsen, Amalie Njølstad, Inger 2021-03-29 https://hdl.handle.net/10037/23027 https://doi.org/10.1093/eurjpc/zwab050 eng eng Cambrigde University Press European Journal of Preventive Cardiology (EJPC) Hopstock LA, Morseth B, Cook S, Eggen AE, Grimsgaard sg, Lundblad MW, Løchen M, Mathiesen EB, Nilsen A, Njølstad i. Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke. European Journal of Preventive Cardiology (EJPC). 2021 FRIDAID 1952450 doi:10.1093/eurjpc/zwab050 2047-4873 2047-4881 https://hdl.handle.net/10037/23027 openAccess Copyright 2021 The Author(s) VDP::Medical disciplines: 700::Health sciences: 800::Community medicine Social medicine: 801 VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801 Journal article Tidsskriftartikkel Peer reviewed publishedVersion 2021 ftunivtroemsoe https://doi.org/10.1093/eurjpc/zwab050 2021-11-17T23:54:38Z Aims - To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway. Methods and results - In the population-based Tromsø Study 2015–16 (attendance 65%), 904 participants had previous validated MI and/or stroke. Cross-sectionally, we investigated target achievement for blood pressure (<140/90 mmHg, <130/80 mmHg if diabetes), LDL cholesterol (<1.8 mmol/L), HbA1c (<7.0% if diabetes), overweight (body mass index (BMI) <25 kg/m2, waist circumference women <80 cm, men <94 cm), smoking (non-smoking), physical activity (self-reported >sedentary, accelerometer-measured moderate-to-vigorous ≥150 min/week), diet (intake of fruits ≥200 g/day, vegetables ≥200 g/day, fish ≥200 g/week, saturated fat <10E%, fibre ≥30 g/day, alcohol women ≤10 g/day, men ≤20 g/day), and medication use (antihypertensives, lipid-lowering drugs, antithrombotics, and antidiabetics), using regression models. Proportion of target achievement was for blood pressure 55.2%, LDL cholesterol 9.0%, HbA1c 42.5%, BMI 21.1%, waist circumference 15.7%, non-smoking 86.7%, self-reported physical activity 79%, objectively measured physical activity 11.8%, intake of fruit 64.4%, vegetables 40.7%, fish 96.7%, saturated fat 24.3%, fibre 29.9%, and alcohol 78.5%, use of antidiabetics 83.6%, lipid-lowering drugs 81.0%, antihypertensives 75.9%, and antithrombotics 74.6%. Only 0.7% achieved all cardiovascular risk factor targets combined. Largely, there was little difference between the sexes, and in characteristics, medication use, and lifestyle among target achievers compared to non-achievers. Conclusion - Secondary prevention of cardiovascular disease was suboptimal. A negligible proportion achieved the treatment target for all risk factors. Improvement in follow-up care and treatment after MI and stroke is needed. Article in Journal/Newspaper Tromsø University of Tromsø: Munin Open Research Archive Norway Tromsø European Journal of Preventive Cardiology 29 2 362 370 |
institution |
Open Polar |
collection |
University of Tromsø: Munin Open Research Archive |
op_collection_id |
ftunivtroemsoe |
language |
English |
topic |
VDP::Medical disciplines: 700::Health sciences: 800::Community medicine Social medicine: 801 VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801 |
spellingShingle |
VDP::Medical disciplines: 700::Health sciences: 800::Community medicine Social medicine: 801 VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801 Hopstock, Laila Arnesdatter Morseth, Bente Cook, Sarah Eggen, Anne Elise Grimsgaard, Sameline Lundblad, Marie Wasmuth Løchen, Maja-Lisa Mathiesen, Ellisiv B. Nilsen, Amalie Njølstad, Inger Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke |
topic_facet |
VDP::Medical disciplines: 700::Health sciences: 800::Community medicine Social medicine: 801 VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801 |
description |
Aims - To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway. Methods and results - In the population-based Tromsø Study 2015–16 (attendance 65%), 904 participants had previous validated MI and/or stroke. Cross-sectionally, we investigated target achievement for blood pressure (<140/90 mmHg, <130/80 mmHg if diabetes), LDL cholesterol (<1.8 mmol/L), HbA1c (<7.0% if diabetes), overweight (body mass index (BMI) <25 kg/m2, waist circumference women <80 cm, men <94 cm), smoking (non-smoking), physical activity (self-reported >sedentary, accelerometer-measured moderate-to-vigorous ≥150 min/week), diet (intake of fruits ≥200 g/day, vegetables ≥200 g/day, fish ≥200 g/week, saturated fat <10E%, fibre ≥30 g/day, alcohol women ≤10 g/day, men ≤20 g/day), and medication use (antihypertensives, lipid-lowering drugs, antithrombotics, and antidiabetics), using regression models. Proportion of target achievement was for blood pressure 55.2%, LDL cholesterol 9.0%, HbA1c 42.5%, BMI 21.1%, waist circumference 15.7%, non-smoking 86.7%, self-reported physical activity 79%, objectively measured physical activity 11.8%, intake of fruit 64.4%, vegetables 40.7%, fish 96.7%, saturated fat 24.3%, fibre 29.9%, and alcohol 78.5%, use of antidiabetics 83.6%, lipid-lowering drugs 81.0%, antihypertensives 75.9%, and antithrombotics 74.6%. Only 0.7% achieved all cardiovascular risk factor targets combined. Largely, there was little difference between the sexes, and in characteristics, medication use, and lifestyle among target achievers compared to non-achievers. Conclusion - Secondary prevention of cardiovascular disease was suboptimal. A negligible proportion achieved the treatment target for all risk factors. Improvement in follow-up care and treatment after MI and stroke is needed. |
format |
Article in Journal/Newspaper |
author |
Hopstock, Laila Arnesdatter Morseth, Bente Cook, Sarah Eggen, Anne Elise Grimsgaard, Sameline Lundblad, Marie Wasmuth Løchen, Maja-Lisa Mathiesen, Ellisiv B. Nilsen, Amalie Njølstad, Inger |
author_facet |
Hopstock, Laila Arnesdatter Morseth, Bente Cook, Sarah Eggen, Anne Elise Grimsgaard, Sameline Lundblad, Marie Wasmuth Løchen, Maja-Lisa Mathiesen, Ellisiv B. Nilsen, Amalie Njølstad, Inger |
author_sort |
Hopstock, Laila Arnesdatter |
title |
Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke |
title_short |
Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke |
title_full |
Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke |
title_fullStr |
Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke |
title_full_unstemmed |
Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke |
title_sort |
treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – the tromsø study 2015-2016. secondary prevention in myocardial infarction and stroke |
publisher |
Cambrigde University Press |
publishDate |
2021 |
url |
https://hdl.handle.net/10037/23027 https://doi.org/10.1093/eurjpc/zwab050 |
geographic |
Norway Tromsø |
geographic_facet |
Norway Tromsø |
genre |
Tromsø |
genre_facet |
Tromsø |
op_relation |
European Journal of Preventive Cardiology (EJPC) Hopstock LA, Morseth B, Cook S, Eggen AE, Grimsgaard sg, Lundblad MW, Løchen M, Mathiesen EB, Nilsen A, Njølstad i. Treatment target achievement after myocardial infarction and ischemic stroke: cardiovascular risk factors, medication use and lifestyle – The Tromsø Study 2015-2016. Secondary prevention in myocardial infarction and stroke. European Journal of Preventive Cardiology (EJPC). 2021 FRIDAID 1952450 doi:10.1093/eurjpc/zwab050 2047-4873 2047-4881 https://hdl.handle.net/10037/23027 |
op_rights |
openAccess Copyright 2021 The Author(s) |
op_doi |
https://doi.org/10.1093/eurjpc/zwab050 |
container_title |
European Journal of Preventive Cardiology |
container_volume |
29 |
container_issue |
2 |
container_start_page |
362 |
op_container_end_page |
370 |
_version_ |
1766219297072349184 |